RAM
UTHR icon

Resona Asset Management’s United Therapeutics UTHR Stock Holding History

Resona Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.34M Sell
15,391
-1,334
-8% -$751K 0.04% 372
2026
Q1 		$9.91M Sell
16,725
-417
-2% -$208K 0.05% 317
2025
Q4 		$8.38M Sell
17,142
-1,140
-6% -$531K 0.04% 365
2025
Q3 		$7.67M Sell
18,282
-3,558
-16% -$1.2M 0.04% 400
2025
Q2 		$6.27M Buy
21,840
+1,521
+7% +$455K 0.03% 456
2025
Q1 		$6.26M Buy
20,319
+787
+4% +$270K 0.04% 405
2024
Q4 		$6.9M Sell
19,532
-1,211
-6% -$445K 0.04% 374
2024
Q3 		$7.43M Sell
20,743
-819
-4% -$277K 0.04% 370
2024
Q2 		$6.87M Sell
21,562
-2,480
-10% -$656K 0.04% 373
2024
Q1 		$5.52M Buy
+24,042
New +$5.43M 0.03% 454

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Resona Asset Management's UTHR Position: Q2 2026 in Review

Resona Asset Management reduced its United Therapeutics (UTHR) stake by 8% in Q2 2026, selling an estimated $751K and leaving 15,391 shares worth $8.34M. The position accounts for 0.04% of the portfolio, ranked #372.

Resona Asset Management first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.91M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Resona Asset Management held 15,391 shares of United Therapeutics worth $8.34M as of Q2 2026.
  • Resona Asset Management sold 1,334 United Therapeutics shares in Q2 2026, an estimated $751K.
  • United Therapeutics made up 0.04% of Resona Asset Management's portfolio in Q2 2026, its #372 holding.
  • Resona Asset Management first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's United Therapeutics position peaked at $9.91M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.